关于美国CDC相关检测结果的声明函/Declaration letter Regarding CDC 's Assessment and Conclusion
尊敬的各位消费者、销售商及合作伙伴: 

近期,我们关注到涉嫌仿冒瑞德医疗口罩产品被美国疾病控制与预防中心(Centers for Disease Control and Prevention,下称“CDC”)下属机构检测为不合格的有关情况,并就此积极采取措施予以应对。为了澄清有关事实、维护瑞德医疗的声誉及各位消费者、销售商及合作伙伴的利益,我们特发布此份声明函,敬请关注。
 
Dear consumers, distributors and business partners:

Recently, we have learned that a suspected counterfeit RYZUR medical respirator product was assessed as unqualified by a subdivision of the Centers for Disease Control and Prevention (“CDC”), and been actively taking measures to deal with this issue. To clarify relevant facts and to protect RYZUR’s reputation as well as interests of our consumers, distributors and partners, we hereby issue this declaration letter for your information.

请点击连接下载查看详情:
声明函中文版下载:
http://www.ryzur.com.cn/uploadfile/2020/0510/20200510102427817.pdf

声明函英文版(English Version Download)下载:
http://www.ryzur.com.cn/uploadfile/2020/0510/20200510110052992.pdf


瑞德医疗与美国CDC/NIOSH之间关于产品CDC不能确定来源的邮件沟通中英文对照文件下载:
The emails communication between RYZUR Medical and CDC / NIOSH about the issue of the testing result which is showing the products samples tested is uncertain:
http://www.ryzur.com.cn/uploadfile/2020/0510/20200510112701290.pdf